임상 검사 서비스의 세계 시장(제11판)

The definitive global assessment of the clinical laboratory services industry — sized, segmented, and forecast through 2030.

Now in its 11th edition, Kalorama Information’s flagship review of clinical laboratory services gives decision-makers a rigorous, independent read on where diagnostic testing revenue sits today and where it is heading. Built on a 2025 base year, with historical data spanning 2020–2024 and forecasts running through 2030, the report is the reference stakeholders use to size markets, benchmark competitors, and pressure-test strategy against demographic, clinical, technological, and reimbursement realities.

Why this report matters now

Clinical laboratories sit at the center of the diagnostic process and are among the largest end-users of in vitro diagnostics, informing decisions across chemistry, hematology, immunology, microbiology, anatomic pathology, genetics, and molecular diagnostics. The care setting for those tests is shifting quickly — outward to outpatient, ambulatory, retail, and home-based collection, and simultaneously inward, as high-complexity molecular and genomic work concentrates in reference labs, academic centers, and specialty facilities. Layer on aging populations, rising chronic disease burden, oncology’s growing dependence on molecular and companion diagnostics, persistent pricing and reimbursement pressure, staffing shortages, and accelerating consolidation, and the competitive terrain is being redrawn. This edition maps that terrain with data, not conjecture.

What’s inside

Market sizing and forecasts. Global revenues at the service-provider level, with year-by-year historical performance, 2025–2030 projections, and CAGRs supplied for every major segment.

Testing services by specialty. Discrete sizing, trend lines, and growth forecasts for six segments: essential and routine testing (clinical chemistry, hematology, coagulation, endocrinology), immunology and microbiology, cytology and histology, genetic testing, toxicology (drugs of abuse), and COVID-19 — including where post-pandemic normalization is redistributing volume toward traditional and specialized testing.

Market by provider group. Analysis breakdowns across hospital and acute-care labs, physician and outpatient providers, and independent and reference laboratories, contextualized with hospital-bed and physician-density benchmarks and settings such as nursing, home health, dialysis, and pharmacy-based labs.

Regional depth across four regions and 15 countries. North America (United States, Canada); EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland); Asia Pacific (Japan, China, India, South Korea, Australia); and Latin America (Brazil, Mexico) — each with country-level market values, performance histories, and growth projections, plus industry-structure detail for key markets.

Regulatory and reimbursement intelligence. Practical coverage of the forces that move margins: CLIA structure and certification trends, laboratory-developed test regulation, EU IVDR, Medicare reimbursement trajectories, PAMA and the CARES Act, SALSA, ADLT designations, ESRD consolidated billing, commercial-payer dynamics, and pricing transparency.

Competitive analysis and company profiles. A market-share analysis of leading providers plus profiles of the companies shaping global competition — among them ARUP, BioReference Health, DaVita, Eurofins Scientific, Exact Sciences, Guardant Health, H.U. Group, Labcorp, Medicover, Myriad Genetics, Natera, Quest Diagnostics, Siemens Healthineers, Sonic Healthcare, SYNLAB, and Unilabs — with corporate detail, revenue histories, and acquisition, alliance, and partnership activity.

The trends that will define 2025–2030. A dedicated analysis of AI, machine learning, and lab automation; molecular and advanced testing; digital pathology; multiplex testing; personalized medicine; consolidation and centralized networks; pricing and reimbursement pressure; and staffing shortages.

Methodology you can stand behind

Findings draw on primary interviews with industry officials, consultants, providers, and government sources, complemented by secondary research across company filings, databases, investment reports, and medical and business literature. Revenues are recognized at the service-provider level across payer types, with contractual adjustments and fee arrangements accounted for.

Market research for key stakeholders and decision-makers

Worldwide Market for Clinical Laboratory Services, 11th Edition is designed for C-suite executives and strategy teams at diagnostics and laboratory companies, IVD manufacturers benchmarking end-market demand, competitors evaluating market share and white-space opportunities, investors and corporate development teams assessing consolidation prospects, and marketing and commercial leaders seeking a defensible view of segment and regional growth.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

INDUSTRY AT A GLANCE

SCOPE AND METHODOLOGY

GLOBAL MARKET OVERVIEW

• Figure 1-1: Factors Impacting Clinical Lab Demands, 2025
• Table 1-1: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)
• Figure 1-2: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)

KEY ISSUES AND TRENDS AFFECTING THE MARKET

LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

CLINICAL LABORATORY DESCRIPTION

• Figure 2-1: Clinical Laboratory Order
• Figure 2-2: Hospital Length of Stay in Days, by Country, 2021 (Average)

Laboratory Service Payer Types

• Table 2-1: U.S. Clinical Laboratory Revenues, by Client and Payer Type, 2025 (%)
• Figure 2-3: Clinical Laboratory Revenues, by Client and Payer Type, 2025 Estimates (%)

THE LARGEST CLINICAL LABORATORY MARKET: THE UNITED STATES

Structure and Regulation in the U.S.

• Certificate of Waiver
• Table 2-2: Selected CLIA Waived Laboratory Tests
• Certificate of Provider-Performed Microscopy Procedures (PPMP)
• Table 2-3: Provider-Performed Microscopy Procedures
• Certificate of Compliance and Certificate of Accreditation
• Figure 2-4: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), April 2025 (%)
• Table 2-4: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), as of April 2024
• Figure 2-5: Laboratory Certificate Trends, by Application Type, July 2010 – April 2024
• States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
• Table 2-5: CLIA-Exempt States, Number of Laboratories, as of April 2024

CLINICAL LABORATORY IMPROVEMENT AND QUALITY

LABORATORY DEVELOPED TEST REGULATIONS

• Directive 2017/746 (IVDR)

PAYERS AND REIMBURSEMENT

• Figure 2-6: Positive Forces and Negative Forces Impacting Clinical Laboratory Services, 2026

Trends in Medicare Reimbursement

• Figure 2-7: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2025

Protecting Access to Medicare Act (PAMA) of 2014

Impact of CARES Act on PAMA

• Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2027 (%)
• Saving Access to Laboratory Service Act (SALSA)

Advanced Laboratory Tests (ADLT)

• Table 2-7: List of Approved ADLTs, 2025

Bundled Insurance Payments for ESRD Patients

• Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing, CY 2025

Commercial Insurance Providers

• Table 2-9: National Commercial Insurance Provider List Revenues, 2025 (US$ billion)
• Figure 2-8: National Commercial Insurance Providers by Membership and Total Revenues, 2025 (US$ billion)

TRANSPARENCY IN PRICING

THE ROLE OF INFORMATION TECHNOLOGY

• Table 2-10: Selected Laboratory Information Management System Providers, 2025 Vendor List

INDUSTRY DRIVERS

Global Demographics

• Table 2-11: The Global Population, 1980-2060 (millions)
• Figure 2-9: The Global Population, 1980-2060 (in millions of population)
• Regional Population Overview
• Table 2-12: World Population by UN-Defined Geographic Region, 2010–2060 (millions)
• Figure 2-10: World Population by UN-Defined Geographic Region, 2010–2060 (in millions of population)
• Aging Populations
• Table 2-13: Global Population Trends Age 65+, 2000-2060 (population in millions)
• Figure 2-11: Global Population Trends Age 65+, 2000-2060 (population in millions)

Chronic Diseases and Conditions

• Figure 2-12: Global Prevalence of Disease, 2000, 2015 and Projected 2030 (in millions of population)
• Figure 2-13: Leading Causes of Death Globally, 2021 (number of deaths in millions)

Economic Performance

• Health Expenditures
• Figure 2-14: Global Health Spending as a Percentage of GDP, by Country, 2023 estimates (%)

Laboratory Performance Drivers and Challenges

• Drivers
• Challenges

CHAPTER THREE: TESTING SERVICES BY SPECIALTY

TEST AND SERVICES OVERVIEW

• Figure 3-1: Global Clinical Laboratory Market Analysis, Service Revenue Trend, 2020-2030 (US$ millions)
• Table 3-1: Global Clinical Laboratory Market Analysis, by Test Segment, 2020-2030 (US$ millions at the manufacturer’s level) [Clinical Chemistry: Routine & Essential, COVID-19, Cytology & Histology, Genetic, Immunology & Microbiology, Toxicology]
• Figure 3-2: Global Clinical Laboratory Market Analysis, by Segment Growth Forecast, 2025-2030 (%) [Clinical Chemistry: Routine & Essential, COVID-19, Cytology & Histology, Genetic, Immunology & Microbiology, Toxicology]
• Figure 3-3: Global Clinical Laboratory Market Analysis by Testing Service, Distribution of Revenues, 2025 (%) [Clinical Chemistry: Routine & Essential, COVID-19, Cytology & Histology, Genetic, Immunology & Microbiology, Toxicology]

CLINICAL CHEMISTRY - ROUTINE AND ESSENTIAL TESTING

• Figure 3-4: Global Clinical Laboratory Market Analysis, Clinical Chemistry: Routine & Essential Testing Service Market Trend, 2020-2030 ($ millions)
• Table 3-2: Market Overview - Routine and Essential Testing, 2025 (US$ millions)

Routine Clinical Chemistry

Cholesterol Level Testing

• Table 3-3: High Cholesterol Risk Categories

Urinalysis

• Table 3-4: Normal Reference Levels in a Medical Urinalysis

Hematology

• Blood Cell Count
• Table 3-5: Laboratory Reference Parameters for CBC

Coagulation

Endocrinology

• Thyroid Function Tests
• Pregnancy Testing
• Table 3-6: hCG Levels in Pregnant Women by Days Past Ovulation

IMMUNOLOGY AND MICROBIOLOGY

• Figure 3-5: Global Clinical Laboratory Market Analysis, Immunology & Microbiology Testing Service Market Trend, 2020-2030 ($ millions)
• Table 3-7: Market Overview - Immunology & Microbiology Testing, 2025 (US$ millions)

Allergy and Food Intolerance

Tumor Markers

Cardiac Markers

HIV Testing

CYTOLOGY AND HISTOLOGY TESTING

• Figure 3-6: Global Clinical Laboratory Market Analysis, Cytology & Histology Testing Service Market Trend, 2020-2030 ($ millions)
• Table 3-8: Market Overview - Cytology & Histology Testing, 2025 (US$ millions)
• Pap Test
• Figure 3-7: Percent of Females Aged 30-49 Screened for Cervical Cancer (all screening methods), by Select Country, 2019 Estimates (%)
• Figure 3-8: Summary Recommendations: WHO Suggests Using the Following Strategy for Cervical Cancer Prevention

GENETIC TESTING

• Figure 3-9: Global Clinical Laboratory Market Analysis, Genetic Testing Service Market Trend, 2020-2030 ($ millions)
• Table 3-9: Market Overview - Genetic Testing, 2025 (US$ millions)

TOXICOLOGY TESTING

• Figure 3-10: Global Clinical Laboratory Market Analysis, Toxicology Testing Service Market Trend, 2020-2030 ($ millions)
• Table 3-10: Substance Detection Periods, by Selected Test Method

CHAPTER FOUR: GLOBAL CLINICAL LABORATORY MARKET BY PROVIDER GROUP

CLINICAL LABORATORY MARKET: PROVIDER OVERVIEW

• Table 4-1: Global Clinical Laboratory Market Analysis, by Provider Segment, 2025 and 2030 (US$ millions)
• Figure 4-1: Global Clinical Laboratory Market Analysis, CAGR Forecast by Provider Segment, 2025–2030 (%)
• Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues, 2025 (%)

HOSPITALS AND ACUTE CARE PROVIDERS

• Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market 2025 and 2030 (U.S./International Estimates) (US$ millions)
• Figure 4-3: Hospital Beds per 1,000 Population, by Country, 2023/2024
• Figure 4-4: Global Visualization - Hospital Beds per 1,000 Population, by Country, 2023/2024

PHYSICIANS AND OUTPATIENT CARE PROVIDERS

• Figure 4-5: Physician-based Laboratory Testing Markets, 2023-2025 (US$ millions)
• Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market 2025 and 2030 (U.S./International Estimates) (US$ millions)

Physician Offices

• Figure 4-6: Medical Doctors per 1,000 Population by Country, 2023/2024
• Figure 4-7: Global Visualization - Medical Doctors per 1,000 Population by Country, 2023/2024

Global Nursing Establishments and Assisted Living Facilities

Global Dialysis Clinics

INDEPENDENT LABORATORY PROVIDERS

• Figure 4-8: Independent Laboratory Testing Markets, 2023-2025 (US$ millions)
• Table 4-4: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market 2025 and 2030 (U.S./International Estimates) (US$ millions)

CHAPTER FIVE: NORTH AMERICA MARKET

OVERVIEW

• Table 5-1: North America Market Value by Country, 2025 (US$ millions at the manufacturer’s level)

UNITED STATES

• Table 5-2: United States Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 5-1: United States Clinical Laboratory Service Market, Performance, 2010-2025 (US$ millions)

U.S. Market by Test Type

• Table 5-3: United States Clinical Laboratory Service Market, by Testing Services, Estimates and Forecast 2025 and 2030 (US$ millions) [COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology]
• Figure 5-2: U.S. Clinical Laboratory Market Analysis, Testing Service Revenues by Type, 2025 (%) [COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology]
• Figure 5-3: U.S. Clinical Laboratory Market Analysis, Testing Service Revenues Over Time by Type, 2020-2030 (US$ millions) [COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology]

U.S. Market by Laboratory Provider Type

• Table 5-4: United States Clinical Laboratory Service Market, by Laboratory Type, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 5-4: United States Clinical Laboratory Market Share, by Laboratory Type, 2025 (%)
• Figure 5-5: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues Over Time by Laboratory Type, 2020-2030 (US$ millions)

U.S. Clinical Laboratory Industry Structure

• Figure 5-6: Growth in Clinical Laboratories, 2000-2024
• CLIA Laboratory Registration, Laboratories by Type
• Figure 5-7: U.S. CLIA Clinical Laboratory Registration, by Primary Laboratory/Facility Type, May 2024 (number of labs)
• Table 5-5: CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), May 2024
• Figure 5-8: Growth Trends in CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), June 2020 and May 2024
• Figure 5-9: Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, Percent Change, Compounded Annually 2020-2024 (%)

Independent Clinical Laboratories

• Figure 5-10: Leading U.S. Independent Laboratory Groups, Distribution of Centers, 2025 (%)
• Growth in Independent Clinical Laboratories
• Figure 5-11: Growth in U.S. Independent Laboratory Facilities, June 2011 through April 2024 (number of laboratories)

Hospital-based Laboratories

• U.S. Hospital Data
• Table 5-6: U.S. Hospital Types
• Table 5-7: AHA Statistics - U.S. Registered Hospitals, by Type, 2011 through 2024
• Table 5-8: AHA Statistics for U.S. Hospitals, 2015-2024
• U.S. Hospital Stay Stats
• Figure 5-12: U.S. Hospital Length of Stay, Average by Broad Age Group, 2021 (days of hospital stay)
• Growth in Hospital Clinical Laboratories
• Figure 5-13: Growth in U.S. Hospital Laboratory Locations, June 2011 through April 2024 (number of laboratories)
• Number of U.S. Physicians
• Growth in Clinical Laboratories in the Physician's Office
• Figure 5-14: Growth in U.S. Physician Office Laboratory Locations, June 2011 through April 2024 (number of laboratories)

Nursing Facility and Home Health

• U.S. Nursing Home Establishments
• U.S. Home Health Facilities
• Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
• Figure 5-15: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011 through April 2024 (number of laboratories)

Pharmacy-based Laboratories

• Growth in Pharmacy-Based Clinical Laboratories
• Figure 5-16: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through April 2024 (number of laboratories)

Dialysis Clinics

• Growth in U.S. Dialysis Clinics and Affiliated Laboratories
• Figure 5-17: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through April 2024 (number of laboratories)

CANADA

• Table 5-9: Canada Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 5-18: Canada Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER SIX: EMEA MARKET

OVERVIEW

• Table 6-1: EMEA Market Value, by Country, 2025 (US$ millions at the manufacturer’s level)
• Figure 6-1: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2025-2030 (%)

GERMANY

• Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 6-2: Germany Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)
• Figure 6-3: Germany’s Leading Laboratory Service Suppliers, by Estimated Distribution of Revenues, 2025 (%)

FRANCE

• Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 6-4: France Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

ITALY

• Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 6-5: Italy Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

SPAIN

• Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 6-6: Spain Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

UNITED KINGDOM

• Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 6-7: United Kingdom Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

SWITZERLAND

• Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 6-8: Switzerland Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER SEVEN: ASIA PACIFIC MARKET

OVERVIEW

• Table 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2025
• (US$ millions at the manufacturer’s level)
• Figure 7-1: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2025-2030 (%)

JAPAN

• Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 7-2: Japan Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions) Japan Clinical Laboratory Industry Structure
• Figure 7-3: Japan Clinical Laboratory Industry, by Type, 2025 (%)
• Figure 7-4: Japan Clinical Laboratory Industry, by Test Classification, 2023-2024 (%)
• Figure 7-5: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2025 (%)

CHINA

• Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 7-6: China Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions) China Clinical Laboratory Industry Structure
• Figure 7-7: China Clinical Laboratory Industry, by Type, 2025 (%)

INDIA

• Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 7-8: India Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

SOUTH KOREA

• Table 7-5: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 7-9: South Korea Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

AUSTRALIA

• Table 7-6: Australia Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 7-10: Australia Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER EIGHT: LATIN AMERICA MARKET

OVERVIEW

• Table 8-1: Latin America Market Value, by Country, 2025 (US$ millions at the manufacturer’s level)
• Figure 8-1: Latin America Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2025-2030 (%)

BRAZIL

• Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 8-2: Brazil Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

MEXICO

• Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2025 and 2030 (US$ millions)
• Figure 8-3: Mexico Clinical Laboratory Service Market, Performance 2010-2025 (US$ millions)

CHAPTER NINE: LEADING MARKET PARTICIPANTS

GLOBAL COMPETITOR SUMMARY

• Figure 9-1: Market Participants, Global Service Revenues, Estimated 2024 and 2025 (US$ millions) U.S. COMPETITIVE ANALYSIS
• Table 9-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2025 (US$ millions)
• Figure 9-2: Estimated U.S. Laboratory Service Market Share Among Leading Clinical Laboratory Providers, 2025 (%)
• Figure 9-3: Top 15 Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2025 (US$ millions)

SELECT COMPANY PROFILES

ARUP LABORATORIES

Company Overview

• Table 9-2: ARUP Laboratories Details
• Figure 9-4: ARUP Labs Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY

Company Overview

• Table 9-3: BioReference Health Corporate Details
• Figure 9-5: BioReference Labs Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

DAVITA

Company Overview

• Table 9-4: DaVita Corporate Details
• Figure 9-6: DaVita Labs Revenues, 2015-2025 (US$ millions)

Products and Services

EUROFINS SCIENTIFIC SE

Company Overview

• Table 9-5: Eurofins Scientific Corporate Details
• Figure 9-7: Eurofins Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

EXACT SCIENCES CORP.

Company Overview

• Table 9-6: Exact Sciences Corporate Details
• Figure 9-8: Exact Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

GUARDANT HEALTH

Company Overview

• Table 9-7: Guardant Health Corporate Details
• Figure 9-9: Guardant Health Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

H.U. GROUP HOLDINGS

Company Overview

• Table 9-8: H.U. Group Holdings, Inc. Corporate Details
• Figure 9-10: H.U Group Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

LABORATORY CORPORATION OF AMERICA (LABCORP)

Company Overview

• Table 9-9: Laboratory Corporation of America Corporate Details
• Figure 9-11: Labcorp Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

MEDICOVER AB

Company Overview

• Table 9-10: Medicover Corporate Details
• Figure 9-12: Medicover Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

MYRIAD GENETICS, INC.

Company Overview

• Table 9-11: Myriad Genetics Corporate Details
• Figure 9-13: Myriad Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

NATERA

Company Overview

• Table 9-12: Natera Corporate Details
• Figure 9-14: Natera Revenues, 2019-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

QUEST DIAGNOSTICS, INC.

Company Overview

• Table 9-13: Quest Diagnostics Corporate Details
• Figure 9-15: Quest Diagnostics Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

SIEMENS HEALTHINEERS

Company Overview

• Table 9-14: Siemens Healthineers Corporate Details
• Figure 9-16: Siemens Healthineers Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

SONIC HEALTHCARE LIMITED

Company Overview

• Table 9-15: Sonic Healthcare Corporate Details
• Figure 9-17: Sonic Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

SYNLAB INTERNATIONAL GMBH

Company Overview

• Table 9-16: SYNLAB Corporate Details
• Figure 9-18: SYNLAB Revenues, 2015-2025 (US$ millions)

Key Acquisitions, Alliances, and Partnerships

Products and Services

UNILABS

Company Overview

• Table 9-17: Unilabs Corporate Details
• Figure 9-19: Unilabs Revenues, 2015-2025 (US$ millions)

Products and Services

CHAPTER TEN: MARKET TRENDS AND SUMMARY

GLOBAL MARKET OVERVIEW

• Table 10-1: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)
• Figure 10-1: Global Clinical Laboratory Market Analysis, 2020-2030 (US$ millions at the manufacturer’s level)

REGIONAL OVERVIEW

• Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2025 (US$ millions at the manufacturer’s level)
• Figure 10-2: Global Clinical Laboratory Market Analysis, Revenues by Region, 2025 (%)
• Figure 10-3: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2025-2030 (%)

CLINICAL LABORATORY SERVICES ISSUES AND TRENDS

Population growth

Aging populations

Increasing disease burden

Consolidation and Centralized Laboratory Networks

Pricing Pressures in Clinical Laboratory Services

Reimbursement Pressures

Focusing on Efficient health systems

Overall growth in demand for health care services

Laboratory-Developed Tests

Regulatory Developments in Clinical Laboratory Services

Multiplex Testing

AI, Machine Learning and Laboratory Automation Trends

Molecular Testing and Other Advanced Testing Will Open New Avenues

Digital Pathology Trends

Staffing Shortages